NasdaqGS - Nasdaq Real Time Price USD

Treace Medical Concepts, Inc. (TMCI)

5.70 -0.21 (-3.64%)
As of 11:07 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John T. Treace CEO, Founder & Director 1.09M -- 1972
Mr. Mark L. Hair CPA Chief Financial Officer 599.7k -- 1970
Mr. Aaron J. Berutti Senior Vice President of Sales 484.22k -- 1979
Mr. Terry W. Lubben Senior Vice President of Operations -- -- 1965
Mr. Taylor Erickson Chief Information & Security Officer -- -- --
Ms. Julie D. Dewey Chief Communications & Investor Relations Officer -- -- 1961
Mr. Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary -- -- 1975
Mr. Nathan Minnich Senior Vice President of Marketing -- -- --
Mr. Daniel E. Owens Chief Human Resources Officer -- -- 1972
Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer -- -- 1982

Treace Medical Concepts, Inc.

100 Palmetto Park Place
Ponte Vedra, FL 32081
United States
904 373 5940 https://www.treace.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
516

Description

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Corporate Governance

Treace Medical Concepts, Inc.’s ISS Governance QualityScore as of June 1, 2024 is 8. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 8; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 6, 2024 at 10:59 AM UTC - August 12, 2024 at 12:00 PM UTC

Treace Medical Concepts, Inc. Earnings Date

Recent Events

May 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 21, 2024 at 3:00 PM UTC

Annual Shareholders Meeting

May 15, 2024 at 9:20 PM UTC

at Bank of America Health Care Conference

May 9, 2024 at 12:00 AM UTC

S-8: Offering Registrations

May 7, 2024 at 8:30 PM UTC

Q1 2024 Earnings Call

May 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 27, 2024 at 9:30 PM UTC

Q4 2023 Earnings Call

February 27, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 14, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

January 29, 2024 at 12:00 AM UTC

SC 13G: Tender Offer/Acquisition Reports

Related Tickers